Safety and efficacy of BAY 94-9027, an extended-half-life factor VIII, during surgery in patients with severe hemophilia A: Results of the PROTECT VIII clinical trial
Titel:
Safety and efficacy of BAY 94-9027, an extended-half-life factor VIII, during surgery in patients with severe hemophilia A: Results of the PROTECT VIII clinical trial
Auteur:
Santagostino, Elena Lalezari, Shadan Reding, Mark T. Ducore, Jonathan Ng, Heng Joo Poulsen, Lone H. Michaels, Lisa A. Linardi, Camila C.G.